Please use a PC Browser to access Register-Tadawul
ATRenew (NYSE:RERE) Margin Turn Reinforces Bullish Profitability Narratives After Fourth Straight Profitable Quarter
AiHuiShou International Co. Ltd. RERE | 5.66 | +1.07% |
ATRenew (NYSE:RERE) just posted another profitable quarter, with Q3 FY 2025 revenue of C¥5.1b and basic EPS of C¥0.38, while trailing twelve month revenue stood at C¥19.6b and basic EPS at C¥1.17 as the business continued to operate in the black across the past year. The company has seen quarterly revenue move from C¥3.8b in Q2 FY 2024 to C¥4.1b in Q3 FY 2024 and then to C¥5.1b in Q3 FY 2025. Basic EPS shifted from a loss of C¥0.04 in Q2 FY 2024 to C¥0.07 in Q3 FY 2024 and then to C¥0.38 in the latest quarter, setting up a story where investors are likely to focus on how durable these margin gains prove to be.
See our full analysis for ATRenew.With the headline numbers on the table, the next step is to see how this profitability shift lines up with the prevailing narratives around ATRenew and where the latest results might challenge or reinforce those views.
Profitability Holds Across Four Straight Quarters
- ATRenew has reported positive net income excluding extra items for four consecutive quarters, moving from C¥17.9 million in Q3 FY 2024 to C¥90.8 million in Q3 FY 2025, with trailing twelve month net income reaching C¥283.4 million.
- Bulls point to this run of profits as proof that the business model is maturing, but the margins are still quite thin, which keeps execution in focus.
- The bullish narrative highlights multi year earnings growth of about 43.2% per year and expects margins to benefit from higher value services. At the same time, current trailing twelve month EPS of C¥1.17 and a net profit base of C¥283.4 million show that the earnings pool is still relatively modest compared with the near C¥19.6b of trailing revenue.
- Supporters argue that mix shifts such as higher refurbishment and service revenue can lift profitability further, yet the current numbers mean even small changes in costs or pricing could have a visible impact on those profits.
Bulls argue that ATRenew's move to C¥283.4 million of trailing net income may be the early stage of a much larger profit story, and they see the detailed projections and reasoning in 🐂 ATRenew Bull Case as key to judging how realistic that path looks.
Premium P/E Versus Profit History
- The stock trades on a trailing P/E of 30.2x, compared with a peer average of 13.7x and a US Specialty Retail industry average of 18.8x, even though trailing twelve month net income is C¥283.4 million and EPS is C¥1.17.
- Bears focus on this valuation gap and question whether the current profit base justifies such a premium, especially if growth or margin expansion does not follow the more optimistic scripts.
- Skeptics note that a 30.2x multiple on the current C¥1.17 of trailing EPS implies investors are paying a higher price for each unit of earnings than typical peers and the broader industry. This can be a concern if future profitability ends up closer to the recent trailing run rate than to the bullish forecasts.
- At the same time, the business only turned profitable over the last year, so bears argue there is limited history of earnings resilience across cycles, making the elevated multiple more sensitive to any bump in revenue or costs.
Skeptics point out that paying 30.2x earnings for a company with only a year of profitability could be demanding, and 🐻 ATRenew Bear Case walks through that more cautious case using the same profit base and multiple tensions.
DCF Upside Versus High Multiple
- On one hand, the stock price of US$5.58 sits below an indicated DCF fair value of US$7.38, which is roughly 24.4% higher, and also below an analyst price target of about US$7.05. On the other hand, the trailing P/E of 30.2x is above peers at 13.7x and the industry at 18.8x.
- Consensus style narratives lean on that gap between current price and both DCF fair value and analyst target, yet the rich P/E and relatively small trailing profit pool make the picture more balanced than a simple “discount” label suggests.
- The roughly 24.4% difference between the US$5.58 share price and the US$7.38 DCF fair value, along with a similar scale gap to the US$7.05 analyst target, is often cited as upside potential. However, it is based on assumptions that profits grow from the current C¥283.4 million level and that margins improve from recent thin levels.
- At the same time, with the stock already on a 30.2x trailing P/E, any path toward those values likely needs earnings growth to continue beyond the trailing twelve month C¥1.17 EPS. Otherwise, the premium multiple and the discount to DCF and targets start to send mixed signals rather than a straightforward bargain case.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for ATRenew on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
If the mix of bullish and cautious takes here feels split, this is the moment to move quickly and stress test the numbers yourself, starting with 3 key rewards.
See What Else Is Out There
ATRenew pairs a relatively thin profit base and limited history of earnings resilience with a 30.2x P/E that sits well above peers and the industry.
If paying up for that kind of premium makes you uneasy, take a few minutes to scan 50 high quality undervalued stocks that combine more modest valuations with solid fundamentals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.


